> top > docs > PMC:3359311 > spans > 11849-12380 > annotations

PMC:3359311 / 11849-12380 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T13748 103-108 P01584 denotes IL-1β
T13749 297-301 P26993 denotes exsA
T13750 386-390 P26993 denotes exsA
T13751 510-515 P01584 denotes IL-1β
T13752 524-528 P10145 denotes IL-8

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation
T13633 74-81 Gene_expression denotes produce
T13634 82-91 Positive_regulation denotes increased true
T13635 103-108 Protein denotes IL-1β
T13636 289-296 Negative_regulation denotes lacking
T13637 297-301 Protein denotes exsA
T13638 378-385 Negative_regulation denotes lacking
T13639 386-390 Protein denotes exsA
T13640 510-515 Protein denotes IL-1β
R12100 T13633 T13634 themeOf produce,increased
R12101 T13635 T13633 themeOf IL-1β,produce
R12102 T13637 T13636 themeOf exsA,lacking
R12103 T13639 T13638 themeOf exsA,lacking

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T13902 103-108 Protein denotes IL-1β
T13903 74-81 Gene_expression denotes produce
T13904 82-91 Positive_regulation denotes increased
T13905 273-288 Protein denotes aeruginosa PAO1
T13906 297-301 Protein denotes exsA
T13907 289-296 Negative_regulation denotes lacking
T13908 289-296 Negative_regulation denotes lacking
T13909 386-390 Protein denotes exsA
T13910 378-385 Negative_regulation denotes lacking
R12339 T13902 T13903 themeOf IL-1β,produce
R12340 T13902 T13904 themeOf IL-1β,increased
R12341 T13905 T13907 themeOf aeruginosa PAO1,lacking
R12342 T13906 T13908 themeOf exsA,lacking
R12343 T13909 T13910 themeOf exsA,lacking

events-check-again

Id Subject Object Predicate Lexical cue Negation
T13894 74-81 Gene_expression denotes produce
T13895 82-91 Positive_regulation denotes increased true
T13896 103-108 Protein denotes IL-1β
T13897 289-296 Negative_regulation denotes lacking
T13898 297-301 Protein denotes exsA
T13899 378-385 Negative_regulation denotes lacking
T13900 386-390 Protein denotes exsA
T13901 510-515 Protein denotes IL-1β
R12335 T13894 T13895 themeOf produce,increased
R12336 T13896 T13894 themeOf IL-1β,produce
R12337 T13898 T13897 themeOf exsA,lacking
R12338 T13900 T13899 themeOf exsA,lacking

GO-MF

Id Subject Object Predicate Lexical cue
T13877 524-528 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8

GO-BP

Id Subject Object Predicate Lexical cue
T13876 414-423 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T13753 44-49 NNS denotes PBMCs
T13754 50-54 IN denotes from
T13755 55-57 NNP denotes CF
T13756 58-66 NNS denotes patients
T13757 67-69 VBP denotes do
T13758 70-73 RB denotes not
T13759 74-81 VB denotes produce
T13760 82-91 JJ denotes increased
T13761 92-99 NNS denotes amounts
T13762 100-102 IN denotes of
T13763 103-108 NN denotes IL-1β
T13764 108-109 . denotes .
T13765 110-115 NNS denotes PBMCs
T13766 116-120 IN denotes from
T13767 121-123 NNP denotes CF
T13768 124-132 NNS denotes patients
T13769 133-134 -LRB- denotes (
T13770 134-135 FW denotes n
T13771 136-137 SYM denotes =
T13772 138-140 CD denotes 17
T13773 141-143 CD denotes 20
T13774 143-144 -RRB- denotes )
T13775 145-148 CC denotes and
T13776 149-156 JJ denotes healthy
T13777 157-165 NNS denotes controls
T13778 166-167 -LRB- denotes (
T13779 167-168 FW denotes n
T13780 169-170 SYM denotes =
T13781 171-173 CD denotes 15
T13782 174-176 CD denotes 19
T13783 176-177 -RRB- denotes )
T13784 178-182 VBD denotes were
T13785 183-189 VBN denotes primed
T13786 190-194 IN denotes with
T13787 195-198 NNP denotes LPS
T13788 199-200 -LRB- denotes (
T13789 200-202 CD denotes 10
T13790 203-208 NN denotes ng/ml
T13791 208-209 -RRB- denotes )
T13792 210-219 JJ denotes overnight
T13793 220-223 CC denotes and
T13794 224-234 VBN denotes stimulated
T13795 235-239 IN denotes with
T13796 240-242 NNP denotes P.
T13797 243-253 NN denotes aeruginosa
T13798 254-258 NNP denotes PAO1
T13799 259-260 -LRB- denotes (
T13800 260-263 NNP denotes MOI
T13801 264-265 SYM denotes =
T13802 266-267 LS denotes 1
T13803 267-268 -RRB- denotes )
T13804 268-269 , denotes ,
T13805 270-272 NNP denotes P.
T13806 273-283 NNP denotes aeruginosa
T13807 284-288 NNP denotes PAO1
T13808 289-296 VBG denotes lacking
T13809 297-301 NNP denotes exsA
T13810 302-303 -LRB- denotes (
T13811 303-306 NNP denotes MOI
T13812 307-308 SYM denotes =
T13813 309-310 LS denotes 1
T13814 310-311 -RRB- denotes )
T13815 311-312 , denotes ,
T13816 313-316 NNP denotes ATP
T13817 317-318 -LRB- denotes (
T13818 318-319 CD denotes 5
T13819 320-322 NNP denotes mM
T13820 322-323 -RRB- denotes )
T13821 323-324 , denotes ,
T13822 325-327 CC denotes or
T13823 328-332 NNP denotes Poly
T13824 332-333 -LRB- denotes (
T13825 333-335 NNP denotes dA
T13826 335-336 : denotes :
T13827 336-338 NN denotes dT
T13828 338-339 -RRB- denotes )
T13829 340-341 -LRB- denotes (
T13830 341-342 CD denotes 1
T13831 343-345 NN denotes µg
T13832 345-346 NN denotes /
T13833 346-348 NN denotes ml
T13834 348-349 -RRB- denotes )
T13835 350-353 IN denotes for
T13836 354-356 CD denotes 24
T13837 357-362 NNS denotes hours
T13838 362-363 . denotes .
T13839 364-366 NNP denotes P.
T13840 367-377 NN denotes aeruginosa
T13841 378-385 VBG denotes lacking
T13842 386-390 NNP denotes exsA
T13843 391-394 VBD denotes was
T13844 395-399 VBN denotes used
T13845 400-402 IN denotes as
T13846 403-404 DT denotes a
T13847 405-409 NN denotes type
T13848 410-413 NNP denotes III
T13849 414-423 NN denotes secretion
T13850 424-431 NN denotes control
T13851 432-434 IN denotes in
T13852 435-445 NN denotes comparison
T13853 446-450 IN denotes with
T13854 451-460 JJ denotes wild-type
T13855 461-463 NNP denotes P.
T13856 464-474 NN denotes aeruginosa
T13857 474-475 . denotes .
T13858 476-488 NNS denotes Supernatants
T13859 489-493 VBD denotes were
T13860 494-501 VBN denotes assayed
T13861 502-505 IN denotes for
T13862 506-507 -LRB- denotes (
T13863 507-508 NN denotes A
T13864 508-509 -RRB- denotes )
T13865 510-515 NN denotes IL-1β
T13866 516-519 CC denotes and
T13867 520-521 -LRB- denotes (
T13868 521-522 NNP denotes B
T13869 522-523 -RRB- denotes )
T13870 524-528 NN denotes IL-8
T13871 528-529 . denotes .
R12214 T13759 T13759 ROOT produce,produce
R12208 T13753 T13759 nsubj PBMCs,produce
R12209 T13754 T13753 prep from,PBMCs
R12210 T13755 T13756 compound CF,patients
R12211 T13756 T13754 pobj patients,from
R12212 T13757 T13759 aux do,produce
R12213 T13758 T13759 neg not,produce
R12215 T13760 T13761 amod increased,amounts
R12216 T13761 T13759 dobj amounts,produce
R12217 T13762 T13761 prep of,amounts
R12218 T13763 T13762 pobj IL-1β,of
R12219 T13764 T13759 punct .,produce
R12220 T13765 T13770 nsubj PBMCs,n
R12221 T13766 T13765 prep from,PBMCs
R12222 T13767 T13768 compound CF,patients
R12223 T13768 T13766 pobj patients,from
R12224 T13769 T13768 punct (,patients
R12225 T13770 T13770 ROOT n,n
R12226 T13771 T13772 punct =,17
R12227 T13772 T13770 nummod 17,n
R12228 T13773 T13772 appos 20,17
R12229 T13774 T13772 punct ),17
R12230 T13775 T13770 cc and,n
R12231 T13776 T13777 amod healthy,controls
R12232 T13777 T13770 conj controls,n
R12233 T13778 T13777 punct (,controls
R12234 T13779 T13785 nsubjpass n,primed
R12235 T13780 T13781 punct =,15
R12236 T13781 T13779 prep 15,n
R12237 T13782 T13781 appos 19,15
R12238 T13783 T13781 punct ),15
R12239 T13784 T13785 auxpass were,primed
R12240 T13785 T13785 ROOT primed,primed
R12241 T13786 T13785 prep with,primed
R12242 T13787 T13786 pobj LPS,with
R12243 T13788 T13787 punct (,LPS
R12244 T13789 T13790 nummod 10,ng/ml
R12245 T13790 T13787 appos ng/ml,LPS
R12246 T13791 T13790 punct ),ng/ml
R12247 T13792 T13787 conj overnight,LPS
R12248 T13793 T13792 cc and,overnight
R12249 T13794 T13792 conj stimulated,overnight
R12250 T13795 T13794 prep with,stimulated
R12251 T13796 T13798 compound P.,PAO1
R12252 T13797 T13798 compound aeruginosa,PAO1
R12253 T13798 T13795 pobj PAO1,with
R12254 T13799 T13808 punct (,lacking
R12255 T13800 T13808 nsubj MOI,lacking
R12256 T13801 T13802 punct =,1
R12257 T13802 T13800 nummod 1,MOI
R12258 T13803 T13802 punct ),1
R12259 T13804 T13800 punct ",",MOI
R12260 T13805 T13807 compound P.,PAO1
R12261 T13806 T13807 compound aeruginosa,PAO1
R12262 T13807 T13808 nsubj PAO1,lacking
R12263 T13808 T13808 ROOT lacking,lacking
R12264 T13809 T13808 dobj exsA,lacking
R12265 T13810 T13819 punct (,mM
R12266 T13811 T13819 nmod MOI,mM
R12267 T13812 T13813 punct =,1
R12268 T13813 T13811 nummod 1,MOI
R12269 T13814 T13813 punct ),1
R12270 T13815 T13811 punct ",",MOI
R12271 T13816 T13811 conj ATP,MOI
R12272 T13817 T13818 punct (,5
R12273 T13818 T13819 nummod 5,mM
R12274 T13819 T13809 appos mM,exsA
R12275 T13820 T13819 punct ),mM
R12276 T13821 T13809 punct ",",exsA
R12277 T13822 T13809 cc or,exsA
R12278 T13823 T13809 conj Poly,exsA
R12279 T13824 T13823 punct (,Poly
R12280 T13825 T13833 nmod dA,ml
R12281 T13826 T13825 punct :,dA
R12282 T13827 T13825 appos dT,dA
R12283 T13828 T13825 punct ),dA
R12284 T13829 T13833 punct (,ml
R12285 T13830 T13831 nummod 1,µg
R12286 T13831 T13833 nmod µg,ml
R12287 T13832 T13833 compound /,ml
R12288 T13833 T13823 appos ml,Poly
R12289 T13834 T13823 punct ),Poly
R12290 T13835 T13808 prep for,lacking
R12291 T13836 T13837 nummod 24,hours
R12292 T13837 T13835 pobj hours,for
R12293 T13838 T13808 punct .,lacking
R12294 T13839 T13840 compound P.,aeruginosa
R12295 T13840 T13844 nsubjpass aeruginosa,used
R12296 T13841 T13840 acl lacking,aeruginosa
R12297 T13842 T13841 dobj exsA,lacking
R12298 T13843 T13844 auxpass was,used
R12299 T13844 T13844 ROOT used,used
R12300 T13845 T13844 prep as,used
R12301 T13846 T13850 det a,control
R12302 T13847 T13850 compound type,control
R12303 T13848 T13850 compound III,control
R12304 T13849 T13850 compound secretion,control
R12305 T13850 T13845 pobj control,as
R12306 T13851 T13850 prep in,control
R12307 T13852 T13851 pobj comparison,in
R12308 T13853 T13852 prep with,comparison
R12309 T13854 T13856 amod wild-type,aeruginosa
R12310 T13855 T13856 compound P.,aeruginosa
R12311 T13856 T13853 pobj aeruginosa,with
R12312 T13857 T13844 punct .,used
R12313 T13858 T13860 nsubjpass Supernatants,assayed
R12314 T13859 T13860 auxpass were,assayed
R12315 T13860 T13860 ROOT assayed,assayed
R12316 T13861 T13860 prep for,assayed
R12317 T13862 T13863 punct (,A
R12318 T13863 T13861 pobj A,for
R12319 T13864 T13863 punct ),A
R12320 T13865 T13860 advcl IL-1β,assayed
R12321 T13866 T13865 cc and,IL-1β
R12322 T13867 T13868 punct (,B
R12323 T13868 T13865 conj B,IL-1β
R12324 T13869 T13868 punct ),B
R12325 T13870 T13865 conj IL-8,IL-1β
R12326 T13871 T13860 punct .,assayed

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13645 44-49 NN denotes PBMCs
T13646 50-54 IN denotes from
T13647 55-57 NN denotes CF
T13648 58-66 NN denotes patients
T13649 67-69 VB denotes do
T13650 70-73 RB denotes not
T13651 74-81 VB denotes produce
T13652 82-91 VB denotes increased
T13653 92-99 NN denotes amounts
T13654 100-102 IN denotes of
T13655 103-108 NN denotes IL-1β
T13656 110-115 NN denotes PBMCs
T13657 116-120 IN denotes from
T13658 121-123 NN denotes CF
T13659 124-132 NN denotes patients
T13660 133-134 -LRB- denotes (
T13661 134-143 NN denotes n = 17–20
T13662 143-144 -RRB- denotes )
T13663 145-148 CC denotes and
T13664 149-156 JJ denotes healthy
T13665 157-165 NN denotes controls
T13666 166-167 -LRB- denotes (
T13667 167-176 NN denotes n = 15–19
T13668 176-177 -RRB- denotes )
T13669 178-182 VB denotes were
T13670 183-189 VB denotes primed
T13671 190-194 IN denotes with
T13672 195-198 NN denotes LPS
T13673 199-200 -LRB- denotes (
T13674 200-202 CD denotes 10
T13675 203-208 NN denotes ng/ml
T13676 208-209 -RRB- denotes )
T13677 210-219 JJ denotes overnight
T13678 220-223 CC denotes and
T13679 224-234 VB denotes stimulated
T13680 235-239 IN denotes with
T13681 240-242 NNP denotes P.
T13682 243-253 NN denotes aeruginosa
T13683 254-258 NN denotes PAO1
T13684 259-260 -LRB- denotes (
T13685 260-267 NN denotes MOI = 1
T13686 267-268 -RRB- denotes )
T13687 268-269 -COMMA- denotes ,
T13688 270-272 NNP denotes P.
T13689 273-283 NN denotes aeruginosa
T13690 284-288 NN denotes PAO1
T13691 289-296 VB denotes lacking
T13692 297-301 NN denotes exsA
T13693 302-303 -LRB- denotes (
T13694 303-310 NN denotes MOI = 1
T13695 310-311 -RRB- denotes )
T13696 311-312 -COMMA- denotes ,
T13697 313-316 NN denotes ATP
T13698 317-318 -LRB- denotes (
T13699 318-319 CD denotes 5
T13700 320-322 NN denotes mM
T13701 322-323 -RRB- denotes )
T13702 323-324 -COMMA- denotes ,
T13703 325-327 CC denotes or
T13704 328-332 NNP denotes Poly
T13705 332-333 -LRB- denotes (
T13706 333-335 NN denotes dA
T13707 335-336 -COLON- denotes :
T13708 336-338 NN denotes dT
T13709 338-339 -RRB- denotes )
T13710 340-341 -LRB- denotes (
T13711 341-342 CD denotes 1
T13712 343-348 NN denotes µg/ml
T13713 348-349 -RRB- denotes )
T13714 350-353 IN denotes for
T13715 354-356 CD denotes 24
T13716 357-362 NN denotes hours
T13717 364-366 NN denotes P.
T13718 367-377 NN denotes aeruginosa
T13719 378-385 VB denotes lacking
T13720 386-390 NN denotes exsA
T13721 391-394 VB denotes was
T13722 395-399 VB denotes used
T13723 400-402 IN denotes as
T13724 403-404 DT denotes a
T13725 405-409 NN denotes type
T13726 410-413 CD denotes III
T13727 414-423 NN denotes secretion
T13728 424-431 NN denotes control
T13729 432-434 IN denotes in
T13730 435-445 NN denotes comparison
T13731 446-450 IN denotes with
T13732 451-460 JJ denotes wild-type
T13733 461-463 NNP denotes P.
T13734 464-474 NN denotes aeruginosa
T13735 476-488 NN denotes Supernatants
T13736 489-493 VB denotes were
T13737 494-501 VB denotes assayed
T13738 502-505 IN denotes for
T13739 506-507 -LRB- denotes (
T13740 507-508 NN denotes A
T13741 508-509 -RRB- denotes )
T13742 510-515 NN denotes IL-1β
T13743 516-519 CC denotes and
T13744 520-521 -LRB- denotes (
T13745 521-522 NN denotes B
T13746 522-523 -RRB- denotes )
T13747 524-528 NN denotes IL-8
R12104 T13645 T13651 arg1Of PBMCs,produce
R12105 T13645 T13646 arg1Of PBMCs,from
R12106 T13645 T13649 arg1Of PBMCs,do
R12107 T13648 T13646 arg2Of patients,from
R12108 T13648 T13647 arg1Of patients,CF
R12109 T13651 T13650 arg1Of produce,not
R12110 T13651 T13649 arg2Of produce,do
R12111 T13653 T13651 arg2Of amounts,produce
R12112 T13653 T13652 arg2Of amounts,increased
R12113 T13653 T13654 arg1Of amounts,of
R12114 T13655 T13654 arg2Of IL-1β,of
R12115 T13656 T13657 arg1Of PBMCs,from
R12116 T13656 T13703 arg1Of PBMCs,or
R12117 T13658 T13669 modOf CF,were
R12118 T13659 T13660 arg1Of patients,(
R12119 T13659 T13663 arg1Of patients,and
R12120 T13661 T13660 arg2Of n = 17–20,(
R12121 T13662 T13660 arg3Of ),(
R12122 T13663 T13669 arg1Of and,were
R12123 T13663 T13670 arg2Of and,primed
R12124 T13665 T13663 arg2Of controls,and
R12125 T13665 T13664 arg1Of controls,healthy
R12126 T13665 T13666 arg1Of controls,(
R12127 T13667 T13666 arg2Of n = 15–19,(
R12128 T13668 T13666 arg3Of ),(
R12129 T13670 T13669 arg2Of primed,were
R12130 T13670 T13671 arg1Of primed,with
R12131 T13672 T13671 arg2Of LPS,with
R12132 T13672 T13673 arg1Of LPS,(
R12133 T13675 T13673 arg2Of ng/ml,(
R12134 T13675 T13674 arg1Of ng/ml,10
R12135 T13676 T13673 arg3Of ),(
R12136 T13677 T13678 arg1Of overnight,and
R12137 T13678 T13687 arg1Of and,","
R12138 T13679 T13678 arg2Of stimulated,and
R12139 T13679 T13680 arg1Of stimulated,with
R12140 T13683 T13680 arg2Of PAO1,with
R12141 T13683 T13681 arg1Of PAO1,P.
R12142 T13683 T13682 arg1Of PAO1,aeruginosa
R12143 T13683 T13684 arg1Of PAO1,(
R12144 T13685 T13684 arg2Of MOI = 1,(
R12145 T13686 T13684 arg3Of ),(
R12146 T13690 T13658 arg1Of PAO1,CF
R12147 T13690 T13677 arg1Of PAO1,overnight
R12148 T13690 T13679 arg2Of PAO1,stimulated
R12149 T13690 T13688 arg1Of PAO1,P.
R12150 T13690 T13689 arg1Of PAO1,aeruginosa
R12151 T13690 T13691 arg1Of PAO1,lacking
R12152 T13690 T13696 arg1Of PAO1,","
R12153 T13692 T13691 arg2Of exsA,lacking
R12154 T13692 T13693 arg1Of exsA,(
R12155 T13694 T13693 arg2Of MOI = 1,(
R12156 T13695 T13693 arg3Of ),(
R12157 T13696 T13657 arg2Of ",",from
R12158 T13697 T13696 arg2Of ATP,","
R12159 T13697 T13698 arg1Of ATP,(
R12160 T13700 T13698 arg2Of mM,(
R12161 T13700 T13699 arg1Of mM,5
R12162 T13701 T13698 arg3Of ),(
R12163 T13703 T13702 arg1Of or,","
R12164 T13703 T13714 arg1Of or,for
R12165 T13704 T13703 arg2Of Poly,or
R12166 T13704 T13705 arg1Of Poly,(
R12167 T13704 T13710 arg1Of Poly,(
R12168 T13706 T13705 arg2Of dA,(
R12169 T13706 T13707 arg1Of dA,:
R12170 T13706 T13708 arg1Of dA,dT
R12171 T13709 T13705 arg3Of ),(
R12172 T13712 T13710 arg2Of µg/ml,(
R12173 T13712 T13711 arg1Of µg/ml,1
R12174 T13713 T13710 arg3Of ),(
R12175 T13716 T13714 arg2Of hours,for
R12176 T13716 T13715 arg1Of hours,24
R12177 T13718 T13717 arg1Of aeruginosa,P.
R12178 T13718 T13719 arg1Of aeruginosa,lacking
R12179 T13718 T13721 arg1Of aeruginosa,was
R12180 T13718 T13722 arg2Of aeruginosa,used
R12181 T13720 T13719 arg2Of exsA,lacking
R12182 T13722 T13721 arg2Of used,was
R12183 T13722 T13723 arg1Of used,as
R12184 T13722 T13729 arg1Of used,in
R12185 T13728 T13723 arg2Of control,as
R12186 T13728 T13724 arg1Of control,a
R12187 T13728 T13725 arg1Of control,type
R12188 T13728 T13726 arg1Of control,III
R12189 T13728 T13727 arg1Of control,secretion
R12190 T13730 T13729 arg2Of comparison,in
R12191 T13730 T13731 arg1Of comparison,with
R12192 T13734 T13731 arg2Of aeruginosa,with
R12193 T13734 T13732 arg1Of aeruginosa,wild-type
R12194 T13734 T13733 arg1Of aeruginosa,P.
R12195 T13735 T13736 arg1Of Supernatants,were
R12196 T13735 T13737 arg2Of Supernatants,assayed
R12197 T13737 T13736 arg2Of assayed,were
R12198 T13737 T13738 arg1Of assayed,for
R12199 T13740 T13739 arg2Of A,(
R12200 T13741 T13739 arg3Of ),(
R12201 T13742 T13739 arg1Of IL-1β,(
R12202 T13742 T13743 arg1Of IL-1β,and
R12203 T13743 T13738 arg2Of and,for
R12204 T13745 T13744 arg2Of B,(
R12205 T13746 T13744 arg3Of ),(
R12206 T13747 T13743 arg2Of IL-8,and
R12207 T13747 T13744 arg1Of IL-8,(

sentences

Id Subject Object Predicate Lexical cue
T13641 44-109 Sentence denotes PBMCs from CF patients do not produce increased amounts of IL-1β.
T13642 110-363 Sentence denotes PBMCs from CF patients (n = 17–20) and healthy controls (n = 15–19) were primed with LPS (10 ng/ml) overnight and stimulated with P. aeruginosa PAO1 (MOI = 1), P. aeruginosa PAO1 lacking exsA (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 µg/ml) for 24 hours.
T13643 364-475 Sentence denotes P. aeruginosa lacking exsA was used as a type III secretion control in comparison with wild-type P. aeruginosa.
T13644 476-529 Sentence denotes Supernatants were assayed for (A) IL-1β and (B) IL-8.
T85 0-109 Sentence denotes 10.1371/journal.pone.0037689.g005 Figure 5 PBMCs from CF patients do not produce increased amounts of IL-1β.
T86 110-363 Sentence denotes PBMCs from CF patients (n = 17–20) and healthy controls (n = 15–19) were primed with LPS (10 ng/ml) overnight and stimulated with P. aeruginosa PAO1 (MOI = 1), P. aeruginosa PAO1 lacking exsA (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 µg/ml) for 24 hours.
T87 364-475 Sentence denotes P. aeruginosa lacking exsA was used as a type III secretion control in comparison with wild-type P. aeruginosa.
T88 476-529 Sentence denotes Supernatants were assayed for (A) IL-1β and (B) IL-8.